Latest News and Press Releases

Westford, USA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- CAR T-Cell Therapy Market size was valued at USD 7.27 billion in 2023 to USD 106.06 billion by 2031, growing at a CAGR of 39.80% during the forecast...

Ottawa, July 01, 2024 (GLOBE NEWSWIRE) -- The global CAR T-cell therapy market size is predicted to increase from USD 8.44 billion in 2023 to approximately USD 107.92 billion by 2033, According to...

New York, United States, April 18, 2024 (GLOBE NEWSWIRE) -- The Global CAR T-Cell Therapy Market Size is to Grow from USD 4.29 Billion in 2023 to USD 21.92 Billion by 2033, at a Compound Annual...

Rockville, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global car T-cell therapy market, estimated to be valued at US$ 2.25 million in 2024, is projected to increase at a stupendous CAGR of 17.7% from...

Wilmington, New Castle,  Delaware, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “CAR T-Cell Therapy Market Size, Share, Competitive Landscape and Trend...

Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The CAR T-cell therapy market was estimated to have acquired US$ 1.1 billion in 2020.  It is anticipated to register a 30.6%...

New York, NY, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “CAR T-Cell Therapy Market By Drug Type (Axicabtagene Ciloleucel, Brexucabtagene...

Ottawa, July 27, 2023 (GLOBE NEWSWIRE) -- The global CAR T-Cell therapy market revenue was valued at USD 3,827 million in 2022, a study published by Towards Healthcare a sister firm of Precedence...

Redding, California, May 16, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘CAR T-Cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene...

Farmington, March 30, 2023 (GLOBE NEWSWIRE) -- The global CAR T-Cell Therapy Market Was Valued at USD 1.7 Billion In 2022, And Is Projected to Reach USD 6.1 Billion By 2030, growing at a CAGR Of...